AAF Wealth Management, LLC
Position in ACRV — Acrivon Therapeutics, Inc.
CIK 1726609
WESTBOROUGH, MA
Position in ACRV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$19,006
+$4,164 QoQ
Shares Held
10,678
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#27
of 46 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AAF Wealth Management, LLC holds $19,006 across 1 Biotechnology name. ACRV ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRV |
Acrivon Therapeutics, Inc.
This page
|
10,678 | $19,006 |
All Filings in ACRV
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,006 | 10,678 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $14,842 | 10,678 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $25,733 | 10,678 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $19,327 | 10,678 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $21,676 | 10,678 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $64,281 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2024-09-30 | $74,746 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2024-06-30 | $61,932 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2024-03-31 | $76,347 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2023-12-31 | $52,535 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2023-09-30 | $102,081 | 10,678 | Shares | Sole | 2025-05-19 | |
| 2023-06-30 | $138,386 | 10,678 | Shares | Sole | 2025-05-19 | |
| No filing history on record for this holder in this stock. | ||||||